Correlation Between South American and Assertio Therapeutics
Can any of the company-specific risk be diversified away by investing in both South American and Assertio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining South American and Assertio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between South American Gold and Assertio Therapeutics, you can compare the effects of market volatilities on South American and Assertio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in South American with a short position of Assertio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of South American and Assertio Therapeutics.
Diversification Opportunities for South American and Assertio Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between South and Assertio is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding South American Gold and Assertio Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Assertio Therapeutics and South American is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on South American Gold are associated (or correlated) with Assertio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Assertio Therapeutics has no effect on the direction of South American i.e., South American and Assertio Therapeutics go up and down completely randomly.
Pair Corralation between South American and Assertio Therapeutics
Given the investment horizon of 90 days South American Gold is expected to generate 33.25 times more return on investment than Assertio Therapeutics. However, South American is 33.25 times more volatile than Assertio Therapeutics. It trades about 0.16 of its potential returns per unit of risk. Assertio Therapeutics is currently generating about -0.02 per unit of risk. If you would invest 0.01 in South American Gold on September 2, 2024 and sell it today you would lose (0.01) from holding South American Gold or give up 100.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 99.8% |
| Values | Daily Returns |
South American Gold vs. Assertio Therapeutics
Performance |
| Timeline |
| South American Gold |
| Assertio Therapeutics |
South American and Assertio Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with South American and Assertio Therapeutics
The main advantage of trading using opposite South American and Assertio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if South American position performs unexpectedly, Assertio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Assertio Therapeutics will offset losses from the drop in Assertio Therapeutics' long position.| South American vs. Pacira BioSciences, | South American vs. Collegium Pharmaceutical | South American vs. Prestige Brand Holdings | South American vs. Phibro Animal Health |
| Assertio Therapeutics vs. Amneal Pharmaceuticals, Class | Assertio Therapeutics vs. Lifecore Biomedical | Assertio Therapeutics vs. Ironwood Pharmaceuticals | Assertio Therapeutics vs. Neurocrine Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |